NewAmsterdam Pharma Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026

ConferenceobicetrapibPositive

AI Analysis

Summary

NewAmsterdam Pharma announced it will present data from its obicetrapib development program at the European Society of Cardiology Congress 2026 in Munich on August 28-31, 2026.

Importance:4/10

Sentiment:

0.30

cardiovascularobicetrapibESC Congressdata presentationoral non-statin

Related Companies

$NAMS

Read the original article

Published by GlobeNewswire Pharma on August 26, 2026 12:00 PM

Read Original